Incyte Corporation (NASDAQ:INCY) on 28 January announced that The New England Journal of Medicine (NEJM) published results from the pivotal Phase III RESPONSE clinical trial demonstrating that, compared to standard therapy, Jakafi® (ruxolitinib) significantly improved hematocrit control and reduced spleen volume in patients with polycythemia vera (PV) who had an inadequate response to or had unacceptable side effects from hydroxyurea. On Wednesday shares of Incyte Corporation (NASDAQ:INCY) closed at $73.02. Company’s sales growth for last 5 years was 146.50%.
PulteGroup, Inc. (NYSE: PHM) announced on 29 January financial results for its fourth quarter ended December 31, 2014. For the quarter, PulteGroup reported net income of $217 million, or $0.58 per share. Net income for the period reflects $50 million, or $0.13 per share, of income tax expense. Prior year net income of $220 million, or $0.57 per share, reflects $12 million, or $0.03 per share, of income tax expense. PulteGroup, Inc. (NYSE:PHM) in last trading activity advanced 2.37% to close at $21.59. Company weekly performance is 4.91% while its quarterly performance stands at 11.75%. PulteGroup, Inc. (NYSE:PHM) is -7.26% away from its 52 week high.
Dejour Energy Inc. (NYSE MKT:DEJ) on 27 January updates current development progress underway at the Woodrush/Hunter Project (“Woodrush”) in NE British Columbia. Dejour has successfully tied into production the B-100 Halfway oil step out well and the A-100 Gething gas well from the recently completed 2014 drill program. The two wells are currently producing 350 BOEPD. Logs and production rates from these initiatives have been provided to GLJ, our reservoir engineers for inclusion in the YE 2014 evaluation On last trading day Dejour Energy Inc. (NYSEMKT:DEJ) fell -5.16% to close at $0.15. Its volatility for the week is 7.06% while volatility for the month is 9.78%. DEJ’s sales growth for past 5 years was 5.60% and its EPS growth for past 5 years was 52.20%. Dejour Energy Inc. (NYSEMKT:DEJ) monthly performance is -17.28%.
Zacks downgraded shares of Geeknet (NASDAQ:GKNT) from an outperform rating to a neutral rating in a research note released on Tuesday morning. They currently have $9.90 target price on the stock. Geeknet, Inc. (NASDAQ:GKNT) has 35.06% insider ownership while its institutional ownership stands at 31.50%. In last trading activity company’s stock closed at $7.82.
On 2 February ICICI Bank Ltd.’s (NYSE:IBN) third-quarter fiscal 2015 (ended Dec 31) net profit came in at INR28.89 billion ($458 million), up 14% from the year-ago quarter. Despite this year-over-year improvement, the bank’s ADRs fell over 5% on concerns about the consistent deterioration in its asset quality. On last trading day ICICI Bank Ltd. (NYSE:IBN) fell -1.73% to close at $11.36. Its volatility for the week is 3.87% while volatility for the month is 2.84%. IBN’s sales growth for past 5 years was 6.40% and its EPS growth for past 5 years was 25.00%. ICICI Bank Ltd. (NYSE:IBN) monthly performance is -4.38%.